Mannkind announces new product development

By Danielle Brody

No Comment

Hakan Edstrom, the president, CEO and director of MannKind Corp., a biotech company based in Danbury, this morning announced that the development of pulmonary hypertension and pain management drugs is underway. In the earnings portion of this morning’s conference call, Pfeffer said operating, administrative and research and development expenses have all decreased. The net loss…

This content is for Westfair Online members only. Please login to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.


About the author

Danielle Brody
Danielle is the events manager for Westfair Communications. Previously, she was a reporter for the Fairfield and Westchester County Business Journals. She has written for the Journal News, the Scarsdale Inquirer and the Newark Post. Danielle is a graduate of the University of Delaware.